Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers
|ClinicalTrials.gov Identifier: NCT01535898|
Recruitment Status : Completed
First Posted : February 20, 2012
Last Update Posted : May 8, 2017
|Condition or disease||Intervention/treatment|
|Head and Neck Cancer Prostate Cancer||Other: MRI scanner with sequence|
|Study Type :||Observational|
|Actual Enrollment :||10 participants|
|Official Title:||Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers|
|Study Start Date :||February 2012|
|Actual Primary Completion Date :||February 2015|
|Actual Study Completion Date :||February 2015|
Pts having an MRI
This is a technology assessment protocol. The study is designed to assess the utility of the technology using a limited number of participants.
Other: MRI scanner with sequence
The intervention for the patients is the additional 10 minutes in the MRI scanner with sequence. The intervention for the volunteers is the scan, which will take a total of 30 minutes. The volunteers will have two more additional studies at 1-2 week intervals. Both the patients and volunteers will also need to fill out a questionnaire.
- feasibility of high resolution diffusion-weighted imaging [ Time Frame: 2 years ]using a new DWI pulse sequence from the manufacturer (General Electric Medical Systems (Milwaukee, WI)) for the assessment of head and neck cancer cancer and prostate cancer.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01535898
|United States, New York|
|Memorial Sloan Kettering Cancer Center|
|New York, New York, United States, 10065|
|Principal Investigator:||Amita Dave, PhD||Memorial Sloan Kettering Cancer Center|